2022
DOI: 10.1590/s0004-2803.20220300075
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy Analysis of Endoscopic Submucosal Dissection for the Early Gastric Cancer and Precancerous Lesions

Abstract: Background: Endoscopic treatment of precancerous lesions and early gastric cancer has been widely accepted in recent years. Endoscopic submucosal dissection (ESD), following established indication criteria, can lead to cure of the disease in more than 90% of cases. Objective: This study aimed to analyze the use of ESD in patients with early gastric cancer and precancerous lesions, as well as the results of the procedure, its complications and effectiveness in controlling the disease. Methods: This is a retr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 12 publications
0
1
0
Order By: Relevance
“…The excellent performance of AI methods in the diagnosis of gastric cancer can also be explained by the characteristic morphological characteristics of these tumors. Namely, according to the Paris classification, gastric carcinomas are most often type IIa (elevated lesion), alone or in combination with type IIc (depressed lesion), as IIa+IIc or IIc+IIa [ 53 ]. Changes in the mucosal and vascular pattern are certainly important.…”
Section: Early Gastric Carcinomamentioning
confidence: 99%
“…The excellent performance of AI methods in the diagnosis of gastric cancer can also be explained by the characteristic morphological characteristics of these tumors. Namely, according to the Paris classification, gastric carcinomas are most often type IIa (elevated lesion), alone or in combination with type IIc (depressed lesion), as IIa+IIc or IIc+IIa [ 53 ]. Changes in the mucosal and vascular pattern are certainly important.…”
Section: Early Gastric Carcinomamentioning
confidence: 99%